4,086
Total Claims
$458K
Drug Cost
284
Beneficiaries
$1,614
Cost/Patient
Peer Comparison vs. 106,889 Family Practice providers
-23%
Opioid rate vs peers
2.0% vs 2.6% avg
+51%
Cost per patient vs peers
$1,614 vs $1,068 avg
+37%
Brand preference vs peers
12.3% vs 9.0% avg
Opioid Prescribing
2.0%
Opioid Rate
81
Opioid Claims
$1,003
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
88% generic
Brand: 498 claims · $373K
Generic: 3,547 claims · $83K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Empagliflozin | 53 | $74K |
| Sitagliptin Phosphate | 42 | $55K |
| Linagliptin | 29 | $37K |
| Apixaban | 26 | $36K |
| Mirabegron | 29 | $28K |
| Insulin Glargine,hum.Rec.Anlog | 17 | $11K |
| Fluticasone/Vilanterol | 20 | $11K |
| Tiotropium Bromide | 16 | $8,072 |
| Insulin Glargine,hum.Rec.Anlog | 17 | $6,923 |
| Umeclidinium Bromide | 15 | $5,489 |
| Atorvastatin Calcium | 353 | $5,211 |
| Tamsulosin Hcl | 130 | $3,896 |
| Levothyroxine Sodium | 146 | $2,119 |
| Rosuvastatin Calcium | 61 | $2,080 |
| Metformin Hcl | 166 | $2,073 |
Prescribing Profile
83
Unique Drugs
$165K
Patient Profile
73
Avg Age
35%
Female
0.99
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data